144 related articles for article (PubMed ID: 2756171)
1. Mathematical models in quantitative assessment of carcinogenic risk.
Park CN
Regul Toxicol Pharmacol; 1989 Jun; 9(3):236-43. PubMed ID: 2756171
[TBL] [Abstract][Full Text] [Related]
2. The linearized multistage model and the future of quantitative risk assessment.
Crump KS
Hum Exp Toxicol; 1996 Oct; 15(10):787-98. PubMed ID: 8906427
[TBL] [Abstract][Full Text] [Related]
3. Quantitative risk assessment and the limitations of the linearized multistage model.
Lovell DP; Thomas G
Hum Exp Toxicol; 1996 Feb; 15(2):87-104. PubMed ID: 8645508
[TBL] [Abstract][Full Text] [Related]
4. Commentary on EPA carcinogen risk assessment guidelines.
Moolenaar RJ
Regul Toxicol Pharmacol; 1989 Jun; 9(3):230-5. PubMed ID: 2756170
[TBL] [Abstract][Full Text] [Related]
5. Quantitative factors in chemical carcinogenesis: variation in carcinogenic potency.
Krewski D; Szyszkowicz M; Rosenkranz H
Regul Toxicol Pharmacol; 1990 Aug; 12(1):13-29. PubMed ID: 2217915
[TBL] [Abstract][Full Text] [Related]
6. Estimating risk for carcinogenic environmental contaminants and its impact on regulatory decision making.
Cothern CR; Marcus WL
Regul Toxicol Pharmacol; 1984 Sep; 4(3):265-74. PubMed ID: 6494499
[TBL] [Abstract][Full Text] [Related]
7. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
McClellan RO
Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594
[TBL] [Abstract][Full Text] [Related]
8. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
[TBL] [Abstract][Full Text] [Related]
9. Biologically based models for risk assessment.
Portier CJ; Hoel DG; Kaplan NL; Kopp A
IARC Sci Publ; 1990; (104):20-8. PubMed ID: 2228117
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cancer risk estimates based on a variety of risk assessment methodologies.
Gold LS; Gaylor DW; Slone TH
Regul Toxicol Pharmacol; 2003 Feb; 37(1):45-53. PubMed ID: 12662908
[TBL] [Abstract][Full Text] [Related]
11. Development of quantitative structure-activity relationship (QSAR) models to predict the carcinogenic potency of chemicals. II. Using oral slope factor as a measure of carcinogenic potency.
Wang NC; Venkatapathy R; Bruce RM; Moudgal C
Regul Toxicol Pharmacol; 2011 Mar; 59(2):215-26. PubMed ID: 20951756
[TBL] [Abstract][Full Text] [Related]
12. Approaches to cancer assessment in EPA's Integrated Risk Information System.
Gehlhaus MW; Gift JS; Hogan KA; Kopylev L; Schlosser PM; Kadry AR
Toxicol Appl Pharmacol; 2011 Jul; 254(2):170-80. PubMed ID: 21034767
[TBL] [Abstract][Full Text] [Related]
13. Science policy choices and the estimation of cancer risk associated with exposure to TCDD.
Gough M
Risk Anal; 1988 Sep; 8(3):337-42. PubMed ID: 2849149
[TBL] [Abstract][Full Text] [Related]
14. Topics in cancer risk assessment.
Olin SS; Neumann DA; Foran JA; Scarano GJ
Environ Health Perspect; 1997 Feb; 105 Suppl 1(Suppl 1):117-26. PubMed ID: 9114281
[TBL] [Abstract][Full Text] [Related]
15. Use of 'secondary mechanism' in the regulation of carcinogens; a chronology.
Scheuplein RJ
Cancer Lett; 1995 Jun; 93(1):103-12. PubMed ID: 7600537
[TBL] [Abstract][Full Text] [Related]
16. Comparative carcinogenicity of the PAHs as a basis for acceptable exposure levels (AELs) in drinking water.
Rugen PJ; Stern CD; Lamm SH
Regul Toxicol Pharmacol; 1989 Jun; 9(3):273-83. PubMed ID: 2756174
[TBL] [Abstract][Full Text] [Related]
17. Approaches to the risk assessment of genotoxic carcinogens in food: a critical appraisal.
O'Brien J; Renwick AG; Constable A; Dybing E; Müller DJ; Schlatter J; Slob W; Tueting W; van Benthem J; Williams GM; Wolfreys A
Food Chem Toxicol; 2006 Oct; 44(10):1613-35. PubMed ID: 16887251
[TBL] [Abstract][Full Text] [Related]
18. [The evaluation of occupational exposure to carcinogenic substances: limit values and risk assessments].
Apostoli P; Porru S; Alessio L
G Ital Med Lav; 1990; 12(5-6):201-7. PubMed ID: 2152617
[TBL] [Abstract][Full Text] [Related]
19. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
20. Cancer risk assessment: importance of identifying mechanisms of action.
Bull RJ
J Am Water Works Assoc; 1990 Oct; 82(10):57-60. PubMed ID: 11538297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
